A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
Titel:
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
Auteur:
Salama, J.K. Haraf, D.J. Stenson, K.M. Blair, E.A. Witt, M.E. Williams, R. Kunnavakkam, R. Cohen, E.E.W. Seiwert, T. Vokes, E.E.